Danielle Laliberte
Family · Royal Oak, MINPI 1710785662
Payments from drug & device makers
Across 112 payments — averaging $22.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$246
- AstraZeneca$215
- Novartis$159
- Genentech USA, Inc.$144
- Pharmacosmos Therapeutics Inc.$107
- Geron Corporation$105
- plus $2K from 33 others
What the payments were for
- Food & beverage$2,39796%
- Education$904%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 10 | $246 |
| AstraZeneca(2 entities) | 7 | $215 |
| Novartis | 13 | $159 |
| Genentech USA, Inc. | 12 | $144 |
| Pharmacosmos Therapeutics Inc. | 1 | $107 |
| Geron Corporation | 2 | $105 |
| Tersera Therapeutics LLC | 4 | $102 |
| Lilly USA, LLC | 5 | $95 |
| Daiichi Sankyo Inc. | 4 | $92 |
| Beone Medicines USA, Inc. | 5 | $91 |
| AbbVie | 4 | $87 |
| Caris MPI, Inc. | 3 | $85 |
| Eisai Inc. | 3 | $72 |
| Pharmaessentia USA Corporation | 3 | $71 |
| Bristol Myers Squibb | 4 | $70 |
| Regeneron Healthcare Solutions, Inc. | 2 | $65 |
| Fennec Pharmaceuticals, Inc. | 1 | $65 |
| Karyopharm Therapeutics Inc. | 2 | $51 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $49 |
| Agios Pharmaceuticals, Inc. | 2 | $47 |
| Incyte Corporation | 2 | $41 |
| Johnson & Johnson | 2 | $39 |
| Syndax Pharmaceuticals, Inc. | 2 | $39 |
| Bayer | 2 | $38 |
| Sanofi | 1 | $27 |
| Taiho Oncology, Inc. | 1 | $27 |
| Novocure Inc. | 1 | $26 |
| GSK | 1 | $26 |
| Octapharma USA, Inc. | 1 | $23 |
| Jazz Pharmaceuticals Inc. | 1 | $23 |
| ADC Therapeutics America, Inc. | 1 | $22 |
| Kyowa Kirin, Inc. | 1 | $21 |
| Boehringer Ingelheim | 1 | $21 |
| Pfizer | 1 | $20 |
| Deciphera Pharmaceuticals Inc. | 1 | $17 |
| Recordati_rare_diseases_inc. | 1 | $17 |
| Spectrum Pharmaceuticals Inc. | 1 | $16 |
| AVEO Pharmaceuticals, Inc. | 1 | $14 |
| Iovance Biotherapeutics, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Monoferric$107
How this compares
$2,487 in reported general payments places this provider in the 85th percentile of 3,657 family providers in Michigan.
Other family in Royal Oak
- Jayme HeimGrandville$663K
- Susan WolgamottBloomfield Township$327K
- Elisheva EllenbergDetroit$150K
- Sarah JohnsonFarmington Hills$119K
- Daniela MaximTroy$112K
- Kelsey PrinceGrand Rapids$87K
- Brent MillerFremont$66K
- Rachael CompeauFlint$62K
- David KocendaLapeer$49K
- Tracy RobertsonBay City$47K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.